FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P960016 · Supplement: S093 · Decision Jan 15, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P960016 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
Livewire™ TC XLS™
PMA Number
P960016
Supplement Number
S093
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
January 15, 2026
Date Received
December 17, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

an alternate vapor degreaser which is used as a processing aid to remove metalworking cutting fluid on patient-contacting tip electrodes and electrode rings during manufacturing

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter